Natus Medical Net Income Growth Trend

BABY -- USA Stock  

USD 36.10  0.05  0.14%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Net Income Growth of Natus Medical Incorporated with missing and latest data points interpolated. Measures the growth in Net Income Common Stock over the specified period.
Net Income Growth10 Years Trend
Increasing
Slightly volatile
 Net Income Growth 
      Timeline 

Regression Statistics

Arithmetic Mean (0.72)
Coefficient Of Variation (505.56)
Mean Deviation  1.96
Median  0.043047
Standard Deviation  3.63
Sample Variance  13.14
Range  16.44
R Value  0.40
Mean Square Error  11.99
R Squared  0.16
Significance  0.17
Slope  0.38
Total Sum of Squares  157.73

Natus Medical Net Income Growth Over Time

2016-12-31  0.043047 
2017-12-31  0.043047 
2018-12-31  0.11 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

Natus Medical Upcoming Company Events
Upcoming Quarterly ReportApril 19, 2017
Next Earnings ReportJuly 19, 2017
Check also analysis of Natus Medical Correlation with competitors. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.